JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120828

Carboplatin, Antitumor agent

Be the first to review this product! Submit a review

|

(3 Publications)

MW 371.25 Da, Purity >99%. Antitumor agent. Forms platinum-DNA adducts blocking DNA replication and transcription. Displays lower nephrotoxicity than analog, cisplatin (ab141398). Active in vivo. .
1 Images
Chemical Structure - Carboplatin, Antitumor agent (AB120828)
  • Chemical Structure

Lab

Chemical Structure - Carboplatin, Antitumor agent (AB120828)

2D chemical structure image of ab120828, Carboplatin, Antitumor agent

Key facts

CAS number

41575-94-4

Purity

>99%

Form

Solid

form

Molecular weight

371.25 Da

Molecular formula

C<sub>6</sub>H<sub>1</sub><sub>2</sub>N<sub>2</sub>O<sub>4</sub>Pt

PubChem

426756

Nature

Synthetic

Solubility

Trifluoroacetic Acid < 1 (mg/mL)

Soluble in water to 25 mM

Soluble in DMSO to 50 mM

Biochemical name

Carboplatin

Biological description

Antitumor agent. Forms platinum-DNA adducts blocking DNA replication and transcription. Displays lower nephrotoxicity than analog, cisplatin (ab141398). Active in vivo.

Canonical smiles

C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]

InChi

InChI=1S/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6;;;/h1-3H2,(H,7,8)(H,9,10);2*1H2;/q;2*-1;+2

InChiKey

VSRXQHXAPYXROS-UHFFFAOYSA-N

IUPAC Name

azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+)

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

eLife 10: PubMed33983115

2021

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Alvaro Gonzalez Rajal,Kamila A Marzec,Rachael A McCloy,Max Nobis,Venessa Chin,Jordan F Hastings,Kaitao Lai,Marina Kennerson,William E Hughes,Vijesh Vaghjiani,Paul Timpson,Jason E Cain,D Neil Watkins,David R Croucher,Andrew Burgess

Cancer science 111:3478-3492 PubMed32648337

2020

Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Feng-Yi Ke,Wan-Yu Chen,Ming-Chieh Lin,Yu-Chyi Hwang,Kuan-Ting Kuo,Han-Chung Wu

eLife 9: PubMed32513387

2020

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jordan F Hastings,Alvaro Gonzalez Rajal,Sharissa L Latham,Jeremy Zr Han,Rachael A McCloy,Yolande Ei O'Donnell,Monica Phimmachanh,Alexander D Murphy,Adnan Nagrial,Dariush Daneshvar,Venessa Chin,D Neil Watkins,Andrew Burgess,David R Croucher
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com